Brain Fiber Bundle Localization via Diffusion MRI Segmentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for analyzing brain fiber bundles are limited in their ability to precisely locate abnormal areas, particularly in cases of decussating fibers, and rely on integral analysis of whole brain or fiber pathways without effective segmentation or machine learning classification.

Innovation Solution

A system that uses diffusion magnetic resonance data to estimate the response function and reconstruct a fiber orientation distribution diffusion model through constrained spherical deconvolution, followed by probabilistic fiber tracing and spherical deconvolution filtering to segment fiber bundles and apply machine learning classification using SVM to identify abnormal nodes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional fiber tracking methods based on diffusion tensor imaging are used, then the fiber bundle pathways can be constructed according to tensor principal orientation, but the method cannot solve the problem of decussating fibers and lacks precision in locating abnormal areas

Engineering Contradiction:
Improveprecision of abnormal area localizationVSAvoidcomplexity of fiber tracking method
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent segments the fiber bundle pathway into multiple nodes along its length, allowing independent analysis of each node's diffusion metrics. This segmentation enables precise localization of abnormal areas by identifying specific nodes with abnormal FA, MD, ICVF, or ODI values, rather than treating the entire fiber bundle as a single unit. The segmentation also helps resolve decussating fiber problems by analyzing local fiber orientation at each node.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs multiple diffusion imaging parameters (FA, MD, ICVF, ODI) to characterize different aspects of white matter integrity and microstructure. By monitoring changes in these parameters across different nodes, the system can precisely identify abnormal areas and differentiate between various types of white matter pathology, improving measurement precision beyond what single-parameter methods can achieve.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If integral analysis of whole brain or fiber pathways is performed, then overall diffusion characteristics can be obtained, but the method lacks effective segmentation and cannot precisely locate abnormal nodes

Engineering Contradiction:
Improveprecision of abnormal node localizationVSAvoidsimplicity of analysis method
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent automatically segments each fiber bundle pathway into multiple equal-length nodes, transforming the integral analysis approach into a segmented analysis framework. This allows the system to maintain the simplicity of automated processing while achieving precise localization of abnormal nodes through comparative analysis of diffusion metrics across segmented nodes, identifying nodes with statistically significant abnormalities.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces machine learning algorithms as intermediaries that automatically identify and classify abnormal nodes based on diffusion metrics. These algorithms process the segmented node data, compare it against normal ranges, and automatically locate abnormal areas, maintaining ease of operation while significantly improving localization precision through intelligent pattern recognition.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Adaptability or versatility

If conventional diffusion tensor imaging is used, then the anisotropy signal can be quantified, but the method cannot effectively handle decussating fibers and complex fiber orientations

Engineering Contradiction:
Improveability to handle decussating fibersVSAvoidprecision of fiber orientation measurement
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The patent transitions from conventional diffusion tensor imaging to advanced diffusion imaging models that compute additional parameters (ICVF, ODI) alongside traditional FA and MD metrics. These additional parameters provide complementary information about fiber density and orientation dispersion, enabling the system to accurately characterize decussating fibers and complex fiber architectures while maintaining measurement precision through multi-parameter analysis.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system enables precise localization of abnormal fiber bundles and focuses on white matter-related disease areas by effectively utilizing imaging indexes from diffusion models and improving the resolution of fiber tracking, particularly addressing the challenge of decussating fibers.

Implementation Method 1

Diffusion-weighted magnetic resonance measures the diffusion movement of water molecules in human body, that is, the displacement of water within a predetermined diffusion time

Methodology Applied
Scientific EffectDiffusion: Diffusion

Implementation Method 2

hydrogen protons in the human body are excited by applying a radio frequency pulse with a certain frequency to the human body in a magnetic field, resulting in resonance

Methodology Applied
Scientific EffectNuclear Magnetic Resonance:

Data Source

PatentUS12274544B2System for precisely locating abnormal area of brain fiber bundle
Publication Date: 2025.04.15 ZHEJIANG LAB
  • US12274544B2 patent drawing
  • US12274544B2 patent drawing

AI summary

A system for precisely locating abnormal areas of brain fiber bundles. The system extracts fiber connections of the whole brain from diffusion magnetic resonance data, and fiber bundle pathways extracts through self-defined fiber bundle pathways or based on brain fiber bundle templates. A selected fiber bundle pathway is projected on a fiber connection result of the whole brain and finely segmented. The imaging indexes such as fractional anisotropy, mean diffusivity, intra-neurite volume fraction and orientation dispersion index are calculated from diffusion magnetic resonance data, so as to obtain the imaging index of each node of each fiber bundle pathway. These imaging indexes are configured to classify the disease group and the healthy group by a machine learning method, and which nodes on which fiber bundle pathways have abnormal changes with different diseases can be precisely located.